Back to top
more

Pgim Jennison Health Sciences Fund Class A: (MF: PHLAX)

(NASDAQ Mutual Funds) As of Apr 16, 2021 08:00 PM ET

 Add to portfolio

$50.12 USD

-0.01 (-0.02%)

Zacks MF Rank More Info

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

2-Buy of 5   2      

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Mar 31, 2021

Total Return %* Percentile Rank Objective
YTD -4.02 89
3 months -4.02 89
6 months 10.38 46
1 Year 56.68 8
3 Year 15.35 46
5 Year 16.30 19
10 Year 17.54 16

* Annual for three years and beyond.

Zacks Premium Research for PHLAX

Zacks MF Rank More Info

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Hold 3
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 44.86
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 3/31/2021 958.96
%Turnover 3/31/2021 45.00

Risk

3 Year 5 Year 10 Year
Beta 0.95 1.00 1.00
Alpha 0.31 0.92 4.46
R Squared 0.61 0.53 0.45
Std. Dev. 22.39 20.49 20.27
Sharpe 0.74 0.85 3.00

Sector / Country Weightings

As of 3/31/2021 % of Portfolio
Health 56.92
Finance 12.46
Services 10.73
Other 8.58
Technology 5.01
Industrial Cyclical 4.64
Retail Trade 1.66

Portfolio Holdings

Top Equity Holdings
(As of 11/30/2020)
% of Portfolio Value (Mil$)
HUMANA INC 5.51 120.36
NATERA INC 3.68 80.38
OTHER 3.10 67.83
APELLIS PHARMACEUTICALS I 3.02 66.09
ASTRAZENECA PLC 2.94 64.21
ABBOTT LABORATORIES 2.84 62.10
SAREPTA THERAPEUTICS INC 2.68 58.65
ELI LILLY & CO 2.48 54.14
VERTEX PHARMACEUTICALS IN 2.36 51.51

Stock Holding % of Net Assets

As Of 11/30/2020
Total Issues 80
Avg. P/E 24.86
Avg. P/Book 4.52
Avg. EPS Growth 5.2
Avg. Market Value (Mil $) 47,945

Allocation

% of Portfolio
Large Growth 9.81
Large Value 0.00
Small Growth 18.41
Small Value 0.00
Foreign Stock 0.00
Emerging Market 1.30
Precious Metal 0.00
Intermediate Bond 8.97
Foreign Bond 21.44
High Yield Bond 17.48